ANTACID REGULAR WITH ANTI-GAS 200 MG / 5 ML — DIN 02261588
ALUMINUM HYDROXIDE : 200 MG / 5 ML MAGNESIUM HYDROXIDE : 200 MG / 5 ML SIMETHICONE : 20 MG / 5 ML · JAMP PHARMA CORPORATION · LIQUID · wholesale supply in Canada
Health Canada status: DORMANT
What is ANTACID REGULAR WITH ANTI-GAS?
ANTACID REGULAR WITH ANTI-GAS 200 MG / 5 ML contains ALUMINUM HYDROXIDE : 200 MG / 5 ML MAGNESIUM HYDROXIDE : 200 MG / 5 ML SIMETHICONE : 20 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02261588, held by JAMP PHARMA CORPORATION, supplied as LIQUID for ORAL administration. Health Canada currently lists it as dormant, status dated 14-Sep-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
Is there a generic Ordinary Salt Combinations And Antiflatulents in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
28 holders have a Canadian DIN containing Ordinary Salt Combinations And Antiflatulents, across 56 DINs, of which 4 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| LABORATOIRE ATLAS INC | 2 | 2 | ALMAGEL PLUS SUS, STOMAAX PLUS | Sourceable in Canada |
| PHARMASCIENCE INC | 3 | 1 | GELUSIL ANTACID & ANTI-GAS, GELUSIL ANTACID AND ANTI-GAS, PMS-ALUMINA MAG AND SIMETHICONE SUS | Sourceable in Canada |
| HALEON CANADA ULC | 1 | 1 | TUMS CHEWY BITES WITH GAS RELIEF | Sourceable in Canada |
| NOVARTIS CONSUMER HEALTH CANADA INC. | 7 | 0 | MAALOX ADVANCED ANTACID & ANTIGAS, MAALOX ADVANCED EXTRA STRENGTH ANTACID & ANTIGAS, MAALOX ADVANCED EXTRA STRENGTH ANTACID & ANTIGAS CHEWABLE TABLETS, MAALOX PLUS EXTRA STRENGTH TABLETS, MAALOX PLUS SUSPENSION EXTRA STRENGTH, +2 more | No marketed DIN |
| RHONE-POULENC RORER CONSUMER INC. | 6 | 0 | MAALOX PLUS EXTRA STRENGTH (CHERRY), MAALOX PLUS SUSPENSION EXTRA STRENGTH, MAALOX PLUS SUSPENSION MINT FLAVOUR, MAALOX PLUS TAB, MAALOX PLUS TABLETS LEMON FLAVOUR, +1 more | No marketed DIN |
| CHURCH & DWIGHT CANADA CORP | 4 | 0 | DIOVOL PLUS ALUMINUM FREE, DIOVOL PLUS ALUMINUM FREE SUSPENSION, DIOVOL PLUS SUSPENSION, DIOVOL PLUS TABLETS | No marketed DIN |
| JAMP PHARMA CORPORATION | 3 | 0 | ANTACID PLUS EXTRA STRENGTH, ANTACID REGULAR WITH ANTI-GAS, ANTACID WITH ALUMINA, MAGNESIA PLUS SIMETHICONE ORAL SUSPENSION USP | No marketed DIN |
| KSL PHARMACEUTICALS | 2 | 0 | ANTACID CHEWABLE TAB, ANTACID PLUS ANTIFLATULENT | No marketed DIN |
| MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | 2 | 0 | MYLANTA TABLETS DOUBLE STRENGTH, MYLANTA TABLETS REGULAR STRENGTH | No marketed DIN |
| PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | 2 | 0 | MYLANTA LIQUID EXTRA STRENGTH SUS, MYLANTA LIQUID REGULAR STRENGTH SUS | No marketed DIN |
| PRODUITS FRANCAIS LABS INC. | 2 | 0 | IDIGEL PLUS TAB, INDIGEL PLUS LIQUID | No marketed DIN |
| SANOFI CONSUMER HEALTH INC | 2 | 0 | ROLAIDS EXTRA STRENGTH MULTI-SYMPTOM TABLETS, ROLAIDS ULTRA STRENGTH PLUS GAS | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 200 MG / 5 ML |
|---|---|
| Dosage form | LIQUID |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Ordinary Salt Combinations And Antiflatulents |
|---|---|
| ATC code | A02AF02 |
| AHFS class | 08:18.08.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02261588 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2261588 |
| Brand name | ANTACID REGULAR WITH ANTI-GAS |
| Generic / active ingredient | ALUMINUM HYDROXIDE : 200 MG / 5 ML MAGNESIUM HYDROXIDE : 200 MG / 5 ML SIMETHICONE : 20 MG / 5 ML |
| Market authorization holder | JAMP PHARMA CORPORATION |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A02AF02 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A02AF |
| Current status | DORMANT |
| Status date | 14-Sep-2017 |
| Original market date | 2005-02-23 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
4 of 56 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALMAGEL PLUS SUS | 200 MG / 5 ML | SUSPENSION | LABORATOIRE ATLAS INC | MARKETED | 00815527 |
| GELUSIL ANTACID AND ANTI-GAS | 25 MG | TABLET (CHEWABLE) | PHARMASCIENCE INC | MARKETED | 02409836 |
| STOMAAX PLUS | 25 MG / 5 ML | SUSPENSION | LABORATOIRE ATLAS INC | MARKETED | 00623709 |
| TUMS CHEWY BITES WITH GAS RELIEF | 750 MG | TABLET (CHEWABLE) | HALEON CANADA ULC | MARKETED | 02540274 |
| ANTACID & ANTIGAS | 20.00 MG / 5 ML | SUSPENSION | GERI-CARE PHARMACEUTICALS CORP. | CANCELLED (UNRETURNED ANNUAL) | 02410095 |
| ANTACID CHEWABLE TAB | 200 MG | TABLET | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | 00391700 |
| ANTACID CHEWABLE TAB | 200 MG | TABLET | KSL PHARMACEUTICALS | CANCELLED POST MARKET | 00886505 |
| ANTACID LIQUID SUSP | 200 MG / 5 ML | SUSPENSION | SHOPPERS DRUG MART INC. | CANCELLED POST MARKET | 00417920 |
| ANTACID PLUS - SUS | 200 MG / 5 ML | SUSPENSION | WES PAK PRODUCTS LTD. | CANCELLED POST MARKET | 02226855 |
| ANTACID PLUS ANTIFLATUENT | 200 MG / 5 ML | SUSPENSION | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | 00854638 |
2 · Same class — other molecules in ATC A02AF
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ordinary Salt Combinations And Antiflatulents | ALMAGEL PLUS SUS · ANTACID & ANTIGAS · ANTACID CHEWABLE TAB · ANTACID LIQUID SUSP · +50 more | 56 | 4 | Yes |
| Magaldrate And Antiflatulents | RIOPAN PLUS SUS · RIOPAN PLUS SUSPENSION · RIOPAN PLUS TABLETS | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A02AX | Antacids, Other Combinations | 14 | 2 |
| A02AA | Magnesium Carbonate · Magnesium Hydroxide | 14 | 0 |
| A02AB | Aluminium Hydroxide | 1 | 0 |
| A02AC | Calcium Carbonate | 16 | 0 |
| A02AD | Magaldrate · Ordinary Salt Combinations | 47 | 0 |
| A02AH | Antacids With Sodium Bicarbonate | 9 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.